The widespread success of clinical implantology stems from bone's ability to form rigid, load-bearing connections to titanium and certain bioactive coatings. Adhesive biomolecules in the extracellular matrix are presumably responsible for much of the strength and stability of these junctures. Histochemical and spectroscopic analyses of retrievals have been supplemented by studies of osteoblastic cells cultured on implant materials and of the adsorption of biomolecules to titanium powder. These data have often been interpreted to suggest that proteoglycans permeate a thin, collagen-free zone at the most intimate contact points with implant surfaces. This conclusion has important implications for the development of surface modifications to enhance osseointegration. The evidence for proteoglycans at the interface, however, is somewhat less than compelling due to the lack of specificity of certain histochemical techniques and to possible sectioning artifacts. With this caveat in mind, we have devised a working model to explain certain observations of implant interfaces in light of the known physical and biological properties of bone proteoglycans. This model proposes that titanium surfaces accelerate osseointegration by causing the rapid degradation of a hyaluronan meshwork formed as part of the wound-healing response. It further suggests that the adhesive strength of the thin, collagen-free zone is provided by a bilayer of decorin proteoglycans held in tight association by their overlapping glycosaminoglycan chains.
References
1.
Albrektsson T., Hansson H-A. (1986). An ultrastructural characterization of the interface between bone and sputtered titanium or stainless steel surfaces. Biomaterials7:201-205.
2.
Albrektsson T., Branemark P-I., Hansson H-A., Ivarsson B., Jonsson U. (1982). Ultrastructural analysis of the interface zone of titanium and gold implants. In: Clinical applications of biomaterials. Lee AJC, Albrektsson T, Branemark P-I, editors. New York: John Wiley & Sons, pp. 167-177.
3.
Albrektsson T., Branemark P-I., Hansson H-A., Kasemo B., Larsson K., Lundstrom I., et al. (1983). The interface zone of inorganic implants in vivo: titanium implants in bone. Ann Biomed Eng11:1-27.
4.
Albrektsson T., Hansson H-A., Ivarsson B. (1985). Interface analysis of titanium and zirconium bone implants. Biomaterials6:97-101.
5.
Beresford J., Fedarko N., Fisher L., Midura R., Yanagashita M., Termine J., et al. (1987). Analysis of the proteoglycans synthesized by human bone cells in vitro. J Biol Chem262:17164-17172.
6.
Bertolami CN, Messadi DV (1994). The role of proteoglycans in hard and soft tissue repair. Crit Rev Oral Biol Med5:311-337.
7.
Branemark P-I., Adell R., Albrektsson T., Carlsson G., Haraldson T., Lekholm U., et al. (1982). Osseointegrated titanium implants in the rehabilitation of the edentulous patient. In: Clinical applications of biomaterials. Lee AJC, Albrektsson T, Branemark P-I, editors. New York: John Wiley & Sons, pp. 133-141.
8.
Branford-White CJ (1978). Molecular organization of heparan sulfate proteoglycans from human dentine. Arch Oral Biol23:1141-1144.
9.
Brown DC, Vogel KG (1989). Characteristics of the in vitro interaction of a small proteoglycan (PG II) of bovine tendon with type I collagen. Matrix9:468-478.
10.
Brunski J., Hipp J., Cochran G. (1989). The influence of biomechanical factors at the tissue-biomaterial interface. Mater Res Soc Symp Proc110:505-515.
11.
Caterson B., Calabro T. Hampton A. (1987). Monoclonal antibodies as probes for elucidating proteoglycan structure and function. In: Biology of proteoglycans. Wight TN, Mecham RP, editors. Orlando, FL: Academic Press, pp. 1-26.
12.
Chehroudi B., Ratkay J., Brunette DM (1992). The role of implant surface geometry on mineralization in vivo and in vitro: A transmission and scanning electron microscopic study. Cells Mater2:89-104.
13.
Chen C., Boskey A. (1986). The effects of proteoglycans from different cartilage types on in vitro hydroxyapatite proliferation. Calcif Tissue lnt39:324-327.
14.
Cheng H., Caterson B., Neame P., Lester G., Yamauchi M. (1996). Differential distribution of lumican and fibromodulin in tooth cementum. Connect Tissue Res34:87-96.
15.
Chintala SK, Miller RR, McDevitt CA (1994). Basic fibroblast growth factor binds to heparan sulfate in the extracellular matrix of rat growth plate chondrocytes. Arch Biochem Biophys310:180-186.
16.
Collis JJ, Embery G. (1992). Adsorption of glycosaminoglycans to commercially pure titanium. Biomaterials13:548-552.
17.
Dammer U., Popescu O., Wagner P., Anselmetti D., Giintherodt H-J., Misevic GN (1995). Binding strength between cell adhesion proteoglycans measured by atomic force microscopy. Science267:1173-1175.
18.
Davies JE (1996). In vitro modeling of the bone/implant interface. Anat Rec245:426-445.
19.
Davies JE, Lowenberg B., Shiga A. (1990). The bone-titanium interface in vitro. J Biomed Mater Res24:1289-1306.
20.
Davies JE, Ottensmeyer P., Shen X., Hashimoto M., Peel SAF (1991). Early extracellular matrix synthesis. In: The bone-biomaterial interface. Davies JE, editor. Toronto, Canada: University of Toronto Press, pp. 214-228.
21.
De Bruijn JD, Flach FS, De Groot K., Van Blitterswijk CA, Davies JE (1993). Analysis of the bony interface with various types of hydroxyapatite in vitro. Cells Mater3:115-127.
22.
De Lange GL, De Putter C., De Wijs FLJA (1990). Histological and ultrastructural appearance of the hydroxyapatite-bone interface. J Biomed Mater Res24:829-845.
23.
Ducheyne P. (1988). Titanium and calcium phosphate ceramic dental implants, surfaces, coatings and interfaces. J Oral Implantol14:325-340.
24.
Dziewiatkowski D., Majznerski L. (1985). Role of proteoglycans in endochondral ossification: inhibition of calcification. Calcif Tissue Int37:560-564.
25.
El-Ghannam A., Ducheyne P., Shapiro IM (1995). Bioactive material template for in vitro synthesis of bone. J Biomed Mater Res29:359-370.
26.
Ellingsen JE (1991) A study on the mechanism of protein adsorption to TiO2. Biomaterials12:593-596.
27.
Fedarko NS, Termine JD, Young MF, Gehron Robey P. (1990). Temporal regulation of hyaluronan and proteoglycan metabolism by human bone cells in vitro. J Biol Chem265:12200-12209.
28.
Fransson L-A., Coster L., Nieduszynski IA, Phelps CF, Sheehan JK (1983). Self-association of copolymeric glycosaminoglycans (proteoglycans). In: Molecular biophysics of the extracellular matrix. Arnott S, Rees DA, Morris ER, editors. Clifton, NJ: Humana Press, pp. 95-118.
29.
Galante J., Lemons J., Spector M., Wilson P., Wright T. (1991). The biologic effects of implant materials. J Ortho Res9:760-775.
30.
Garvey B., Bizios R. (1994). A method for transmission electron microscopy examination of the osteoblast/hydroxyapatite interface. J Appl Biomater5:39-45.
31.
Gehron Robey P. (1989). The biochemistry of bone. Endo Metab Clin N Am18:833-902.
32.
Gehron Robey P. (1996). Vertebrate mineralized matrix proteins: structure and function. Connect Tissue Res35:131-136.
33.
Goldberg HA, Domenicucci C., Pringle G., Sodek J. (1988). Mineral-binding proteoglycans of fetal porcine calvarial bone. J Biol Chem263:12092-12101.
34.
Goldberg R., Toole B. (1987). Hyaluronate inhibition of cell proliferation. Arthr Rheum30:769-778.
35.
Greenwald RA, Moak SA ( 1986). Degradation of hyaluronic acid by polymorphonuclear leukocytes. Inflammation10:15-30.
36.
Hardingham TE, Fosang AJ (1992). Proteoglycans: many forms and many functions. FASEB J6:861-870.
37.
Hayat MA (1989). Principles and techniques of electron microscopy. Biological applications. 3rd ed. Boca Raton, FL: CRC Press, pp. 285-289.
38.
Higuchi Y., Matukawa F., Ashida T., Gonda Y. (1995). Studies of glycosaminoglycans to titanium implants in the diabetic rat (abstract). J Dent Res74:435.
39.
Hildebrand A., Romarís M., Rasmussen L., Heinegard D., Twardzik D., Border W., et al. (1994). Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor β. Biochem J302:527-534.
40.
Hunter GK, Szigety SK (1992). Effects of proteoglycan on hydroxyapatite formation under non-steady-state and pseudo-steady-state conditions. Matrix12:362-368.
41.
lozzo RV, Murdoch AD (1996). Proteoglycans of the extracellular environment: clues from the gene and protein side offer novel perspectives in molecular diversity and function. FASEB J10:598-614.
42.
James R. (1973). A histopathological study of the nature of the epithelium surrounding implant posts. Oral Implantol3:137-159.
43.
Johansson C., Lausmaa J., Ask M., Hansson H-A., Albrektsson T. (1989). Ultrastructural differences of the interface zone between bone and Ti6Al4V or commercially pure titanium. J Biomed Eng11:3-8.
44.
Kieswetter K., Schwartz Z., Dean D., Boyan B. (1996). The role of implant surface characteristics in the healing of bone. Crit Rev Oral Biol Med7:329-345.
45.
Kinne RW, Schmitz HJ, Gross U. (1988). Collagenous and non-collagenous bone proteins in rats and rabbits at the bone-implant interface of bone-bonding and nonbonding glass-ceramic. In: Implant materials in bio-function. De Putter C, De Lange GL, De Groot K, Lee AJC, editors. Amsterdam: Elsevier, pp. 73-78.
46.
Klinger MM, Rahemtulla F., Prince CW, Lucas LC (1995). Proteoglycans synthesized by osteoblast-like MC3T3-E I cells on cp-Ti (abstract). Ann Biomed Eng23(Suppl 1):S-100.
47.
Klinger MM, Rahemtulla F., Prince CW, Lucas LC (1996a). Proteoglycans at the bone-biomaterial interface in vitro (abstract). In: Abstracts, Fifth World Biomaterials Congress. Vol. II, p. 427.
48.
Klinger MM, Rahemtulla F., Prince CW, Lucas LC (1996b). Adsorption of proteoglycans to titanium powder (abstract). Ann Biomed Eng24(Suppl. 1):S-76.
49.
Klinger MM, Rahemtulla F., Prince CW, Lucas LC (1997). Effect of cations on proteoglycan adsorption to titanium oxides (abstract). In: Abstracts, Society for Biomaterials Annual Meeting, p. 450.
50.
Knudson CB, Knudson W. (1993). Hyaluronan-binding proteins in development, tissue homeostasis, and disease. FASEB J7:1233-1241.
51.
Kobe B., Deisenhofer J. (1994). The leucine-rich repeat: a versatile binding motif. Trends Biochem Sci19:415-421.
52.
Linde A., Lussi A., Crenshaw M. (1989). Mineral induction by immobilized polyanionic proteins. Calcif Tissue Int44:286-295.
53.
Linder L. (1992). Ultrastructure of the bone-cement and the bone-metal interface. Clin Orthop Rel Res276:147-156.
54.
Linder L., Albrektsson T., Branemark P-I., Hansson H-A., Ivarsson B., Jonsson U., et al. (1983). Electron microscopic analysis of the bone-titanium interface. Acta Orthop Scand54:45-52.
55.
Linder L., Obrant K., Boivin G. (1989). Osseointegration of metallic implants. II. Transmission electron microscopy in the rabbit. Acta Orthop Scand60:235-239.
56.
Listgarten MA, Buser D., Steinemann SG, Donath K., Lang NP, Weber HP (1992). Light and transmission electron microscopy of the intact interfaces between non-submerged titanium-coated epoxy resin implants and bone or gingiva. J Dent Res71:364-371.
57.
Lucas LC, Lacefield WR, Ong JL, Whitehead RY (1993). Calcium phosphate coatings for medical and dental implants. Colloids Surf (A) Physicochem Eng Asp77:141-147.
58.
Martin JY, Schwartz Z., Hummert TW, Schraub DM, Simpson J., Lankford J., et al. (1995). Effect of titanium surface roughness on proliferation, differentiation, and protein synthesis of human osteoblast-like cells (MG63). J Biomed Mater Res29:389-401.
59.
McQueen D., Sundgren J-E., Ivarsson B., Lundstrom I., af Ekenstam B., Svensson A., et al. (1982). Auger electron spectroscopic studies of titanium implants. In: Clinical applications of biomaterials. Lee AJC, Albrektsson T, Branemark PI, editors. New York: John Wiley & Sons, pp. 179-185.
60.
McQuillan DJ, Findlay DM, Hocking AM, Yanagashita M., Midura RJ, Hascall VC (1991). Proteoglycans synthesized by an osteoblast-like cell line (UMR 106-01). Biochem J277:199-206.
61.
Merritt K., Brown S. (1993). Release of hexavalent chromium from corrosion of stainless steel and cobalt-chromium alloys. J Biomed Mater Res29:627-633.
62.
Messer RLW, Lucas LC (1996). Metabolic effects of Cr(+3) and Cr(+6) salt solutions (abstract). Ann Biomed Eng24(Suppl. 1):S-76.
63.
Midura RJ, McQuillan DJ, Benham KJ, Fisher LW, Hascall VC (1990). A rat osteogenic cell line (UMR 106-01) synthesizes a highly sulfated form of bone sialoprotein. J Biol Chem265:5285-5291.
64.
Misevic GN, Burger MM (1993). Carbohydrate-carbohydrate interactions of a novel acidic glycan can mediate sponge cell adhesion. J Biol Chem268:4922-4929.
65.
Murai K., Takeshita F., Ayukawa Y., Kiyoshima T., Suetsugu T., Tanaka T. (1996). Light and electron microscopic studies of bone-titanium interface in the tibiae of young and mature rats. J Biomed Mater Res30:523-533.
66.
Nagata T., Goldberg HA, Zhang Q., Domenicucci C., Sodek J. (1991). Biosynthesis of bone proteins by fetal porcine calvariae in vitro. Rapid association of sulfated sialoproteins (secreted phosphoprotein-1 and bone sialoprotein) and chondroitin sulfate proteoglycan (CS-PGIII) with bone mineral. Matrix11:86-100.
67.
Nanci A., McCarthy GF, Zalzal S., Clokie CML, Warshawsky H., McKee MD (1994). Tissue response to titanium implants in the rat tibia: ultrastructural, immunocytochemical and lectin-cytochemical characterization of the bone-titanium interface. Cells Mater4:1-30.
68.
Pan J., Thierry D., Leygraf C. (1996). Hydrogen peroxide toward enhanced oxide growth on titanium in PBS solution: blue coloration and clinical relevance. J Biomed Mater Res30:393-402.
69.
Parsegian VA (1983). Molecular forces governing tight contact between cellular surfaces and substrates. J Prosthet Dent49:838-842.
70.
Pogany G., Hernandez DJ, Vogel KG (1994). The in vitro interaction of proteoglycans with type I collagen is modulated by phosphate. Arch Biochem Biophys313:102-111.
71.
Poole AR, Matsui Y., Hinek A., Lee ER (1989). Cartilage macromolecules and the calcification of cartilage matrix. Anat Rec224:167-179.
72.
Prince CW, Rahemtulla F., Butler WT (1984). Incorporation of [35S]sulphate into glycosaminoglycans by mineralized tissues in vivo. Biochem J224:941-945
73.
Rahemtulla F. (1992). Proteoglycans of oral tissues. Crit Rev Oral Biol Med3:135-162.
74.
Rahemtulla F., Rahemtulla B. (1994). Human gingival fibroblasts (HGF) in primary culture release reactive oxygen species (abstract). J Dent Res73:278.
75.
Ren Z., Brewton R., Mayne R. (1991). An analysis by rotary shadowing of the structure of the mammalian vitreous humor and zonular apparatus. J Struct Biol106:57-63.
76.
Ripellino JA, Klinger MM, Margolis RU, Margolis RK (1985). The hyaluronic acid binding region as a specific probe for the localization of hyaluronic acid in tissue sections. J Histochem Cytochem10:1060-1066.
77.
Roberts CR, Roughley PI, Mort JS ( 1989). Degradation of human proteoglycan aggregate induced by hydrogen peroxide. Protein fragmentation, amino acid modification and hyaluronic acid cleavage. Biochem J259:805-811.
78.
Roden L. (1980). Structure and metabolism of connective tissue proteoglycans. In: The biochemistry of glycoproteins and proteoglycans. Lennarz W, editor. New York: Plenum Press, pp. 267-371.
79.
Roughley PJ, Lee ER (1994). Cartilage proteoglycans: structure and potential functions. Microsc Res Technique28:385-397.
80.
Ruoslahti E., Yamaguchi Y. (1991). Proteoglycans as modulators of growth factor activities. Cell64:867-869.
81.
Schonherr E., Witsch-Prehm P., Harrach B., Robenek H., Rauterberg J., Kresse H. (1995). Interaction of biglycan with type I collagen. J Biol Chem270:2776-2783.
82.
Scott JE (1988). Proteoglycan-fibrillar collagen interactions. Biochem J252:313-323.
83.
Scott JE (1990). Proteoglycan:collagen interactions and subfibrillar structure in collagen fibrils. Implications in the development and ageing of connective tissues. J Anat169:23-35.
84.
Scott JE (1992a). Supramolecular organization of extracellular matrix glycosaminoglycans, in vitro and in the tissues. FASEB J6:2639-2645.
85.
Scott JE (1992b). Morphometry of Cupromeronic blue-stained proteoglycan molecules in animal corneas, versus that of purified proteoglycans stained in vitro, implies that tertiary structures contribute to corneal ultrastructure. ) J Anat180:155-164.
86.
Scott JE (1996). Proteodermatan and proteokeratan sulfate (decorin, lumican/fibromodulin) proteins are horseshoe shaped. Implications for their interactions with collagen. Biochemistry35:8795-8799.
87.
Sebag J., Balazs EA (1989). Morphology and ultrastructure of human vitreous fibers. Invest Ophthalmol Vis Sci30:1867-1871.
88.
Sennerby L., Thomsen P., Ericson LE (1992). Ultrastructure of the bone-titanium interface in rabbits. J Mater Sci:Mater Med3:262-271.
89.
Stanford CM, Keller JC (1991) The concept of osseointegration and bone matrix expression. Crit Rev Oral Biol Med2:83-101.
90.
Steflik DE, Sisk AL, Parr GR, Gardner LK, Hanes PI, Lake FT, et al. (1992). High-voltage electron microscopy and conventional transmission electron microscopy of the interface zone between bone and endosteal dental implants. J Biomed Mater Res26:529-545.
91.
Steflik DE, Sisk AL, Parr GR, Gardner LK, Hanes PJ, Lake FT, et al. (1993). Osteogenesis at the dental implant interface: high-voltage electron microscopic and conventional transmission electron microscopic observations. J Biomed Mater Res27:791-800.
92.
Steflik DE, Sisk AL, Parr GR, Lake FT, Hanes PJ, Berkery DJ, et al. (1994a). Transmission electron and high-voltage electron microscopy of osteocyte cellular processes extending to the dental implant surface. J Biomed Mater Res28:1095-1107.
93.
Steflik DE, Parr GR, Sisk AL, Lake FT, Hanes P.), Berkery DJ, et al. (1994b). Osteoblast activity at the dental implant-bone interface: Transmission electron microscopic and high voltage electron microscopic observations. J Periodontol65:404-413.
94.
Steflik DE, Corpe RS, Lake FT, Sisk AL, Parr GR, Hanes PJ, et al. (1997). Composite morphology of the bone and associated support-tissue interfaces to osseointegrated dental implants: TEM and HVEM analyses. Int J Oral Mcixillofac Implants12:443-453.
95.
Sundgren J-E., Bodo P., Lundstrom I. (1986). Auger electron spectroscopic studies of the interface between human tissue and implants of titanium and stainless steel. J Colloid Interf Sci110:9-20.
96.
Takagi M., Hishikawa H., Hosokawa Y., Kagami A., Rahemtulla F. (1990). Immunohistochemical localization of glycosaminoglycans and proteoglycans in pre-dentin and dentin of rat incisors. J Histochem Cytochem38:319-324.
97.
Takeuchi Y., Matsumoto T., Ogata E., Shishiba Y. (1990). Isolation and characterization of proteoglycans synthesized by mouse osteoblastic cells in culture during the mineralization process. Biochern J266:15-24.
98.
Takeuchi Y., Kodama Y., Matsumoto T. (1994). Bone matrix decorin binds transforming growth factor-β and enhances its bioactivity. J Biol Chem269:32634-32638.
99.
Taylor GC, Waddington RJ, Moseley R., Williams KR, Embery G. (1996). Influence of titanium oxide and titanium peroxy gel on the breakdown of hyaluronan by reactive oxygen species. Biomaterials17:1313-1319.
100.
Tengvall P., Elwing H., Sjoqvist L., Lundstrom I., Bjursten L. (1989a). Interaction between hydrogen peroxide and titanium: a possible role in the biocompatibility of titanium. Biomaterials10:118-120.
101.
Tengvall P., Lundstrom I., Sjoqvist L., Elwing H., Bjursten L. (1989b). Titanium-hydrogen peroxide interaction: model studies of the influence of the inflammatory response on titanium implants. Biomaterials10:166-175.
102.
Tengvall P., Hornsten EG, Elwing H., Lundstrom I. (1990). Bactericidal properties of a titanium-peroxy gel obtained from metallic titanium and hydrogen peroxide. J Biomed Mater Res24:319-330.
103.
Thyberg J., Lohmander S., Heinegard D. (1975). Proteoglycans of hyaline cartilage. Electron-microscopic studies on isolated molecules. Biochem J151:157-166.
104.
Turley EA, Roth S. ( 1980). Interactions between the carbohydrate chains of hyaluronate and chondroitin sulfate. Nature283:268-271.
105.
Uitto V-J., Larjava H. (1991). Extracellular matrix molecules and their receptors: an overview with special emphasis on periodontal tissues. Crit Rev Oral Biol Med2:323-354.
106.
Weigel P., Fuller GM, LeBoeuf RD (1986). A model for the role of hyaluronic acid and fibrin in the early events during the inflammatory response and wound healing. J Theoret Biol119:219-234.
107.
Woods A., Couchman JR (1994). Syndecan 4 heparan sulfate proteoglycan is a selectively enriched and widespread focal adhesion component. Molec Biol Cell5:183-192.
